News & Media

Read more about the article NFX-backed Pepper Bio emerges from stealth with tools to hone in on complex diseases
News

NFX-backed Pepper Bio emerges from stealth with tools to hone in on complex diseases

There’s a clear pain point when it comes to drug discovery: Depending on which study you cite, creating an approved drug costs anywhere from $985 million to $2.6 billion. And R&D returns have rebounded to only about 2.5% in 2020, up from a low of 1.6% in 2019. Not to mention the fact that drugs that fail in clinical trials don’t actually help people who need new treatments. With a…

Comments Off on NFX-backed Pepper Bio emerges from stealth with tools to hone in on complex diseases
October 15, 2021
Read more about the article Pepper Bio Emerges from Stealth with ‘Waze for Drug Discovery’ Technology
Pepper Bio's partnership with Stanford's Dean Felsher will target Myc addicted cancers.
Press Release

Pepper Bio Emerges from Stealth with ‘Waze for Drug Discovery’ Technology

Harvard, MIT, Cambridge, Brown & Northwestern Universities trained team leverages proprietary transomics translation technology to open a new era of drug discovery, rediscovery, and rescue. Pepper Bio, the world’s first transomics drug discovery company, emerges from stealth today to leverage its proprietary transomics -- including phosphoproteomics -- data translation technology to discover new drugs, rediscover new uses for existing therapeutics, and rescue drugs that may be on a course toward…

Comments Off on Pepper Bio Emerges from Stealth with ‘Waze for Drug Discovery’ Technology
October 15, 2021